Cancer Prevalence in Children with Inborn Errors of Immunity: Report from a Single Institution
María Raquel Mitchell,Luciano Urdinez,Andrea R. Bernasconi,Silvia Danielian,María Martha Katsikas,Elisa O. Sajaroff,Georgina Roffé,Nélida M. Villa,Laura Galluzzo,Marianela Sanz,Alejandro M. Palma,Carolina Bouso,Emma Prieto,Verónica Goris,Judith Yancoski,Sergio D. Rosenzweig,Matías Oleastro,Adriana Rosé,Walter Cacciavillano,Guido Felizzia,Myriam Guitter,Cristian Sánchez La Rosa,Mailén Ríos,Pedro Zubizarreta,María Sara Felice,Jorge G. Rossi
DOI: https://doi.org/10.1007/s10875-024-01736-3
IF: 8.542
2024-05-29
Journal of Clinical Immunology
Abstract:Inborn Errors of Immunity (IEI) comprise several genetic anomalies that affect different components of the innate and adaptive responses, predisposing to infectious diseases, autoimmunity and malignancy. Different studies, mostly in adults, have reported a higher prevalence of cancer in IEI patients. However, in part due to the rarity of most of these IEI subtypes (classified in ten categories by the Primary Immunodeficiency Committee of the International Union of Immunological Societies), it is difficult to assess the risk in a large number of patients, especially during childhood.
immunology